April 2012 Drug Information Update - Pharmacy Benefits ...

More documents

Recommendations

Info

Xylocaine 2% - MPF injection, APP 20 mg/mL, 2 mL vial (NDC 63323-0495-27) 20 mg/mL, 5 mL vial (NDC 63323-0495-07) 20 mg/mL, 10 mL ampule (NDC 63323-0496-97) Lidocaine 2% injection, Hospira 20 mg/mL, 2 mL glass ampule, preservative-free (NDC 00409-4282-01) 20 mg/mL, 5 mL vial, preservative-free (NDC 00409-2066-05) 20 mg/mL, 20 mL vial (NDC 00409-4277-01) 20 mg/mL, 50 mL vial (NDC 00409-4277-02) 20 mg/mL, 10 mL glass ampule, preservative-free (NDC 00409-4282-02) 20 mg/mL, 5 mL Ansyr plastic emergency syringes (NDC 00409-1323-05) Lidocaine 4% Xylocaine 4% injection, APP 40 mg/mL, 5 mL glass ampule, preservative-free (NDC 63323-0490-89) Lidocaine 4% injection, Hospira 40 mg/mL, 5 mL glass ampule, preservative-free (NDC 00409-4283-01) Reason for the Shortage • Hospira has lidocaine presentations on shortage due to manufacturing delays. • APP has Xylocaine and lidocaine presentations on shortage due to increased demand for the product. Article link: http://www.ashp.org/DrugShortages/Current/Bulletin.aspx?id=859 Source: www.ashp.org Ciprofloxacin Injection March 28, 2012 Products Affected - Description Ciprofloxacin injection, Claris 2 mg/mL, 100 mL premixed bag (NDC 36000-0008-24) 2 mg/mL, 200 mL premixed bag (NDC 36000-0009-24) Ciprofloxacin injection, Hospira 10 mg/mL, 20 mL vial (NDC 00409-4765-86) 10 mg/mL, 40 mL vial (NDC 00409-4778-86) Ciprofloxacin injection, Sagent 2 mg/mL, 100 mL premixed bag (NDC 25021-0114-82) Ciprofloxacin injection, Teva 2 mg/mL, 100 mL premixed bag (NDC 00703-0969-36) - discontinued 2 mg/mL, 200 mL premixed bag (NDC 00703-0960-36) - discontinued 10 mg/mL, 20 mL vial (NDC 00703-0956-03) - discontinued 10 mg/mL, 40 mL vial (NDC 00703-0958-03) - discontinued Cipro injection, Merck 2 mg/mL, 100 mL premixed bag (NDC 00085-1755-02) - discontinued 2 mg/mL, 200 mL premixed bag (NDC 00085-1741-02) - discontinued 10 mg/mL, 20 mL vial (NDC 00085-1763-03) - discontinued 10 mg/mL, 40 mL vial (NDC 00085-1731-01) - discontinued Reason for the Shortage • Claris has recalled all lots of their ciprofloxacin premixed bags. More information can be found online. • Pfizer discontinued ciprofloxacin injection in 2010. 70
• Teva discontinued all ciprofloxacin injection in September, 2011. • Bedford discontinued ciprofloxacin injection in May, 2011 to concentrate on the manufacturing of other products. • Bayer took over Cipro IV from Merck in 2011. • Hospira has ciprofloxacin vials on shortage due to manufacturing delays. Article link: http://www.ashp.org/DrugShortages/Current/Bulletin.aspx?id=645 Source: www.ashp.org Sodium Bicarbonate Injection March 29, 2012 Products Affected - Descriptio Sodium Bicarbonate Injection 8.4%, Amphastar (IMS) 50 mL syringe, 10 count (NDC 00548-3352-00) 50 mL Min-I-Jet (NDC 00548-1052-00) - discontinued 50 mL Stick-Gard (NDC 00548-2052-00) - discontinued Sodium Bicarbonate Injection 8.4%, American Regent 50 mL vial (NDC 00517-1550-25) - discontinued Sodium Bicarbonate Injection 7.5%, American Regent 50 mL vial (NDC 00517-0639-25) - discontinued Sodium Bicarbonate Injection 4.2%, APP 5 mL vial (NDC 63323-0026-05) Sodium Bicarbonate Injection 4.2%, Hospira 10 mL syringe, 10 count (NDC 00409-5534-34) Sodium Bicarbonate Injection 7.5%, Hospira 50 mL syringe, 10 count (NDC 00409-4916-34) Sodium Bicarbonate Injection 8.4%, Hospira 10 mL syringe, 10 count (NDC 00409-4900-34) 50 mL syringe, 10 count (NDC 00409-6637-34) 50 mL vial, 25 count (NDC 00409-6625-02) Neut 4% sodium bicarbonate additive solution, Hospira 5 mL vial (NDC 00409-6609-02) Reason for the Shortage • American Regent discontinued their sodium bicarbonate 8.4% and 7.5% 50 mL vials in late 2010. • Hospira had sodium bicarbonate on back order due to manufacturing delays and increased demand for product. Hospira discontinued their sodium bicarbonate 8.4% 50 mL Ansyr syringes in August, 2009. • APP has sodium bicarbonate on back order due to increased demand. • Amphastar has sodium bicarbonate on back order due to increased demand. Article link: http://www.ashp.org/DrugShortages/Current/Bulletin.aspx?id=788 Source: www.ashp.org Sodium Acetate Injection March 29, 2012 Products Affected - Description Sodium acetate, American Regent 2 mEq/mL, 20 mL vial (NDC 00517-2096-25) 2 mEq/mL, 100 mL vial (NDC 00517-2500-25) Sodium acetate, APP 71
Page 1 and 2:
April 2012 Drug Information Update
Page 3 and 4:
First-Time Generics GENERIC DRUG NA
Page 5 and 6:
GENERAL ANESTHETICS, INJECTABLE MID
Page 7 and 8:
Gruenhaupt, Mark R.Ph. Argus Health
Page 9 and 10:
Statin Drugs - Drug Safety Communic
Page 11 and 12:
Vytorin (ezetimibe/simvastatin) Tab
Page 13 and 14:
low blood sugar (hypoglycemia) in p
Page 15 and 16:
Some women with depression who beco
Page 17 and 18:
Survival increased for all groups o
Page 19 and 20: finding that it also may reduce the
Page 21 and 22: Syringes (2 mL size), Rx only. NDC
Page 23 and 24: Patheon Pharmaceuticals Inc., Cinci
Page 25 and 26: 50-ct. bottles (NDC 0067-6238-50);
Page 27 and 28: PRODUCT (Class II) 1) Ventolin HFA
Page 29 and 30: Lot #: 0693, Exp: 10/2012 RECALLING
Page 31 and 32: 24 (Display case UPC# 3030045074923
Page 33 and 34: CODE Lot # 139961 RECALLING FIRM/MA
Page 35 and 36: Reason for the Shortage • Teva co
Page 37 and 38: Reason for the Shortage • Ben Ven
Page 39 and 40: Products Affected - Description Gan
Page 41 and 42: 37.5 mg/25 mg, 1000 count (NDC 0078
Page 43 and 44: Acyclovir tablets, Major 400 tablet
Page 45 and 46: 500 mg, 100 count (NDC 63304-0726-0
Page 47 and 48: 750 mg tablets, 100 count (NDC 1013
Page 49 and 50: • Bedford Laboratories has multip
Page 51 and 52: Daunorubicin Hydrochloride Injectio
Page 53 and 54: Ciprofloxacin Immediate-Release Tab
Page 55 and 56: • APP had tobramycin 40 mg/mL pre
Page 57 and 58: • Ben Venue voluntarily suspended
Page 59 and 60: 50 mg/mL, 10 mL vial, package of 10
Page 61 and 62: 2 mL vial, preservative-free (NDC 6
Page 63 and 64: 5 mg single dose vial, package of 1
Page 65 and 66: 20 mL glass ampule, sterile pack (N
Page 67 and 68: 2 mL iSecure syringe (NDC 00406-112
Page 69: Lidocaine 0.5% Xylocaine 0.5% injec
Page 73 and 74: Nicardipine hydrochloride injection
Page 75 and 76: Article link: http://www.ashp.org/D
Page 77 and 78: • Apotex had metformin products u
Page 79: • Covis purchased all rights to F
show all

April 2012 Drug Information Update - Pharmacy Benefits ...

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?